CLINICAL_TRIALS
withdrawal
· 2013-04-04
Clinical Trial Update: Improving Tolerance of Treatment of Pulmonary MAC Infections [Phase 2]
Summary
The Phase 2 trial aimed at improving tolerance of treatment for pulmonary Mycobacterium avium complex infections has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Florida | Conditions: Mycobacterium Avium Complex, Adverse Effects | Phase 2 | Status: WITHDRAWN